Evaluation of Eflornithine Plus Temozolomide in Patients With Newly Diagnosed Glioblastoma or Astrocytoma
מצבים רפואיים
Glioblastoma, IDH-wildtype · Glioblastoma · Glioblastoma Multiforme · Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype · GBM · Astrocytoma · Astrocytoma, IDH-Mutant
סיכום בשפה פשוטהבעזרת בינה מלאכותית
הסיכום נכתב על־ידי מודל שפה והוא ניסיוני. המידע עלול להיות חלקי או שגוי ואינו תחליף לייעוץ רפואי.
מיקומים
University of Alabama at Birmingham, Birmingham, Alabama, United States
Henry Ford Hospital, Detroit, Michigan, United States
Contact: Principal Investigator (Tobias Walbert, MD, PhD, MPH)Columbia University Medical Center - Herbert Irving Pavilion, New York, New York, United States
Contact: Study coordinator (Nurse Navigators) · cancerclinicaltrials@cumc.columbia.edu · 212-342-5162Contact: Principal Investigator (Maria Diaz, MD)Duke University, Durham, North Carolina, United States
Contact: Principal Investigator (Annick Desjardins, MD, FRCPC)The Cleveland Clinic, Cleveland, Ohio, United States
Contact: Principal Investigator (David Peereboom, MD)Brown University Health/Rhode Island Hospital, Providence, Rhode Island, United States
Contact: Principal Investigator (Eric Wong, MD)UT MD Anderson Cancer Center, Houston, Texas, United States
Contact: Principal Investigator (Carlos Kamiya Matsuoka, MD)University of Utah, Huntsman Cancer Institute, Salt Lake City, Utah, United States
Contact: Principal Investigator (Howard Colman, MD, PhD)
מובילי המחקר
Howard Colman, MD, PhD
Principal Investigator
Huntsman Cancer Institute/ University of Utah